• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anika Therapeutics (NQ: ANIK )

    24.27 -0.43 (-1.74%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 41,642
    Open 24.64
    Bid (Size) 10.24 (5)
    Ask (Size) 38.80 (2)
    Prev. Close 24.70
    Today's Range 24.16 - 24.64
    52wk Range 17.88 - 29.11
    Shares Outstanding 14,828,456
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    +7.11%
    +7.11%
    1 Month
    -3.50%
    -3.50%
    3 Month
    -6.11%
    -6.11%
    6 Month
    -5.56%
    -5.56%
    1 Year
    +29.86%
    +29.86%

    More News

    Read More
    Sidoti Events, LLC's Virtual August Micro-Cap Conference
    Via ACCESSWIRE
    Anika Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Anika Therapeutics
    Via Benzinga
    ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Anika to Participate in the Sidoti Virtual Investor Conference
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
    Via Benzinga
    Anika Enters into Cooperation Agreement with Caligan Partners
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 13, 2024
    Via Benzinga
    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Participate in Upcoming Investor Conferences
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
    From Anika Therapeutics Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.